Arkansas
CNS trials open to children and teens in Arkansas
10 CNS studies open to children and teens are recruiting participants at sites in 3 cities across Arkansas as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Arkansas city with a recruiting study
By research area: ADHD (3), Migraine (3), Schizophrenia (3), Depression (1).
Little Rock (10), Glenwood (1), Hot Springs (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
ADHD: recently updated in Arkansas
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT07717892 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Arkansas on ClinicalTrials.gov.
Depression: recently updated in Arkansas
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT06372964 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Arkansas on ClinicalTrials.gov.
Migraine: recently updated in Arkansas
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Little Rock
- Registry record
- NCT06810505 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Little Rock
- Registry record
- NCT05711394 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Glenwood · Hot Springs · Little Rock
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Arkansas on ClinicalTrials.gov.
Schizophrenia: recently updated in Arkansas
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT06229210 · updated
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Phase 4
- Ages 12 to 17
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Recruiting in
- Little Rock
- Registry record
- NCT05648591 · updated
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Alkermes, Inc.
- Recruiting in
- Little Rock
- Registry record
- NCT05303064 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Arkansas on ClinicalTrials.gov.
Ask about studies in Arkansas
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections